Sex hormones and the risk of incident prostate cancer

Urology

Volumn 76, Issue 5, 2010, Pages 1034-1040

  Daniels, Nicholas A ^a   Nielson, Carrie M ^b   Hoffman, Andrew R ^b   Bauer, Douglas C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; TESTOSTERONE BLOOD LEVEL;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; ESTRADIOL; ESTRONE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; GONADAL STEROID HORMONES; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK FACTORS; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE;

EID: 78149361038     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.01.086     Document Type: Article

References (29)

1. P.H. Gann Risk factors for prostate cancer Rev Urol 4 Suppl 5 2002 S3 S10
2. R.B. Hayes, L.M. Pottern, and H. Strickler Sexual behavior, STDs and risks for prostate cancer Br J Cancer 82 2000 718 725
3. K.A. Rosenblatt, K.G. Wicklund, and J.L. Stanford Sexual factors and the risk of prostate cancer Am J Epidemiol 153 2000 1151 1158
4. P.H. Gann, C.H. Hennekens, and J. Ma Prospective study of sex hormone levels and risk of prostate cancer J Natl Cancer Inst 88 1996 1118 1126
5. B.A. Mohr, H.A. Feldman, and L.A. Kalish Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts male aging study Urology 57 2001 930 935
6. P. Stattin, S. Lumme, and L. Tenkanen High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study Int J Cancer 108 2004 418 424
7. N.E. Eaton, G.K. Reeves, and P.N. Appleby Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies Br J Cancer 80 1999 930 934
8. Endogenous Hormones and Prostate Cancer Collaborative Group Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies Roddam AW, (ed.). Nebraska: Allen; Appleby P, Key TJ J Natl Cancer Inst 100 2008 170 183
9. E. Orwoll, J.B. Blank, and E. Barrett-Connor Design and baseline characteristics of the osteoporotic fractures in men (MrOS) studyA large observational study of the determinants of fracture in older men Contemp Clin Trials 26 2005 569 585
10. J.B. Blank, P.M. Cawthon, and M.L. Carrion-Petersen Overview of recruitment for the osteoporotic fractures in men study (MrOS) Contemp Clin Trials 26 2005 557 568
11. A.W. Hsing, F.Z. Stanczyk, and A. Blanger Reproducibility of serum sex steroid assays in men by RIA and mass spectrometry Cancer Epidemiol Biomarkers Prev 16 2007 1004 1008
12. R. Sdergrd, T. Bckstrm, and V. Shanbhag Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature J Steroid Biochem 16 1982 801 810
13. R.L. Prentice, and A. Case-Cohort Design for epidemiologic cohort studies and disease prevention trials Biometrika 73 1986 1 11
14. M.J. Barry, F.J. Fowler, and M.P. O'Leary The American Urological Association symptom index for benign prostatic hyperplasia J Urol 148 1992 1549 1557
15. W.E. Barlow, L. Ichikawa, and D. Rosner Analysis of case-cohort designs J Clin Epidemiol 52 1999 1165 1172
16. R.A. Washburn, K.W. Smith, and A.M. Jette The physical activity scale for the elderly (PASE): development and evaluation J Clin Epidemiol 46 1993 153 162
17. H. Heinzl, A. Kaider, and G. More Flexibility in Cox proportional hazards regression models with cubic spline functions Comput Methods Programs Biomed 54 1997 201 208
18. F. Giton, A. de La Taille, and Y. Allory Estrone sulfate (E1S), a prognosis marker for tumor aggressiveness in prostate cancer (PCa) J Steroid Biochem Mol Biol 109 2008 158 167
19. M.J. Reed, A. Purohit, and L.W. Woo Steroid sulfatase: molecular biology, regulation, and inhibition Endocr Rev 26 2005 171 202
20. Y. Nakamura, T. Suzuki, and T. Fukuda Steroid sulfatase and estrogen sulfotransferase in human prostate cancer Prostate 66 2006 1005 1012
21. T. Shaneyfelt, R. Husein, and G. Bubley Hormonal predictors of prostate cancer: a meta-analysis J Clin Oncol 18 2000 847 853
22. J.K. Parsons, H.B. Carter, and E.A. Platz Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy Cancer Epidemiol Biomarkers Prev 14 2005 2257 2260
23. J.F. Dorgan, D. Albanes, and J. Virtamo Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland Cancer Epidemiol Biomarkers Prev 7 1998 1069 1074
24. M.C. Bosland The role of steroid hormones in prostate carcinogenesis J Natl Cancer Inst Monogr 27 2000 39 66
25. S.J. Fonda, R. Bertrand, and A. O'Donnell Age, hormones, and cognitive functioning among middle-aged and elderly men: cross-sectional evidence from the Massachusetts male aging study J Gerontol A Biol Sci Med Sci 60 2005 385 390
26. H.A. Feldman, C. Longcope, and C.A. Derby Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study J Clin Endocrinol Metab 87 2002 589 598
27. A. Vermeulen, L. Verdonck, and J.M. Kaufman A critical evaluation of simple methods for the estimation of free testosterone in serum J Clin Endocrinol Metab 84 1999 3666 3672
28. R. Li, T. Wheeler, and H. Dai High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy Am J Surg Pathol 28 2004 928 934
29. P.L. Hrknen, and S.I. Mkel Role of estrogens in development of prostate cancer J Steroid Biochem Mol Biol 92 2004 297 305